Citations

Citations to this article as recorded by  

• Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
  Georgette Eskander, Sherihan G. Abdelhamid, Sara A. Wahdan, Sara M. Radwan
  Life Sciences.2025; 362: 123378.     CrossRef
• The Systemic Immune-Inflammation Index and the Risk of Parkinson’s Disease in the U.S.: A Cross-Sectional Study
  Fujun Liu, Qibo Ran, Huajin Zhang, Jing Chen
  Journal of Clinical Medicine.2025; 14(2): 403.     CrossRef
• Recent advances of nanomaterials for intervention in Parkinson’s disease in the context of anti-inflammation
  Ruoyu Zhang, Xiaotong Chen, Yuanyuan Cheng, Zixuan Chen, Xiaoqiong Li, Yulin Deng
  Coordination Chemistry Reviews.2024; 502: 215616.     CrossRef
• Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
  Thuy Thi Lai, Young Eun Kim, Linh Thi Nhat Nguyen, Tinh Thi Nguyen, In Hee Kwak, Franziska Richter, Yun Joong Kim, Hyeo-il Ma
  npj Parkinson's Disease.2024;[Epub]     CrossRef
• New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
  Eveljn Scarian, Camilla Viola, Francesca Dragoni, Rosalinda Di Gerlando, Bartolo Rizzo, Luca Diamanti, Stella Gagliardi, Matteo Bordoni, Orietta Pansarasa
  International Journal of Molecular Sciences.2024; 25(5): 2698.     CrossRef
• Neuroinflammation following anti-parkinsonian drugs in early Parkinson’s disease: a longitudinal PET study
  Tatsuhiro Terada, Tomoyasu Bunai, Takanori Hashizume, Takashi Matsudaira, Masamichi Yokokura, Hirotsugu Takashima, Takashi Konishi, Tomokazu Obi, Yasuomi Ouchi
  Scientific Reports.2024;[Epub]     CrossRef
• The effect of crocin on movement disorders and oxidative DNA damage in Parkinson's disease: Insights from a randomized controlled trial
  Saeed Mohammad Soleymani, Farhad Assarzadegan, Seyed Amir Hassan Habibi, Arash Mahboubi, Hadi Esmaily
  Parkinsonism & Related Disorders.2024; 126: 107051.     CrossRef
• Atractylenolide-I Ameliorates Motor Deficits and Reduces Inflammation of the Spinal Cord by SIRT1/PGC-1α Pathway in MPTP Subacute Mouse Model of Parkinson’s Disease
  Ya Gao, Shuyue Li, Jian Zhang, Yidan Zhang, Yuan Zhao, Shuming Zhang, Lujie Zuo, Guofeng Yang
  Neuropsychiatric Disease and Treatment.2024; Volume 20: 1919.     CrossRef
• Parkinson’s disease is associated with clonal hematopoiesis with TET2 mutation
  Kyung Ah Woo, Han-Joon Kim, Chan Young Lee, Jung Hwan Shin, Choonghyun Sun, Hogune Im, Hongyul An, Jiwoo Lim, Su-Yeon Choi, Youngil Koh, Beomseok Jeon
  npj Parkinson's Disease.2024;[Epub]     CrossRef
• Neuroinflammation and Immune Dysfunction in the Mechanisms of Development of Parkinson’s Disease
  G. V. Idova, E. L. Alperina, S. Ya. Zhanaeva
  Neuroscience and Behavioral Physiology.2023; 53(9): 1534.     CrossRef
• Vitamin D3 actions on astrocyte cells: A target for therapeutic strategy in Parkinson’s disease?
  Erlânia Alves de Siqueira, Emanuel Paula Magalhães, Ramon Róseo Paula Pessoa Bezerra de Menezes, Tiago Lima Sampaio, Danya Bandeira Lima, Conceição da Silva Martins, Kelly Rose Tavares Neves, Gerly Anne de Castro Brito, Alice Maria Costa Martins, Glauce S
  Neuroscience Letters.2023; 793: 136997.     CrossRef
• ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
  Ran Zheng, Yiqun Yan, Shaobing Dai, Yang Ruan, Ying Chen, Chenjun Hu, Zhihao Lin, Naijia Xue, Zhe Song, Yi Liu, Baorong Zhang, Jiali Pu
  Journal of Neuroinflammation.2023;[Epub]     CrossRef
• NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
  Qiu-Qin Han, Weidong Le
  Neuroscience Bulletin.2023; 39(5): 832.     CrossRef
• The Role of Ubiquitin–Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease
  Yu Liang, Guangshang Zhong, Mingxin Ren, Tingting Sun, Yangyang Li, Ming Ye, Caiyun Ma, Yu Guo, Changqing Liu
  NeuroMolecular Medicine.2023; 25(4): 471.     CrossRef
• Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson’s disease of male rats
  Sadegh Moradi Vastegani, Seyed Esmaeil Khoshnam, Samireh Ghafouri, Nima Bakhtiari, Yaghoob Farbood, Alireza Sarkaki, Wesley Lyeverton Correia Ribeiro
  PLOS ONE.2023; 18(11): e0294612.     CrossRef
• NEUROINFLAMMATION AND IMMUNE DYSFUNCTION IN THE PATHOGENESIS OF PARKINSON’S DISEASE
  G. V. Idova, E. L. Alperina, S. Ya. Zhanaeva
  Журнал высшей нервной деятельности им. И.П. Павлова.2023; 73(4): 454.     CrossRef
• A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
  Andrea Spinaci, Catia Lambertucci, Michela Buccioni, Diego Dal Ben, Claudia Graiff, Maria Cristina Barbalace, Silvana Hrelia, Cristina Angeloni, Seyed Khosrow Tayebati, Massimo Ubaldi, Alessio Masi, Karl-Norbert Klotz, Rosaria Volpini, Gabriella Marucci
  Molecules.2022; 27(8): 2386.     CrossRef
• Oligomeropathies, inflammation and prion protein binding
  Gianluigi Forloni, Pietro La Vitola, Claudia Balducci
  Frontiers in Neuroscience.2022;[Epub]     CrossRef